> >Register Now <<

Join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: Neuroimaging to Enhance Precision in Clinical Trials

Speaker: Aristotle Voineskos, MD, PhD, FRCPC

This Grand Rounds explores how the upcoming use of neuroimaging is being used to better direct clinical care. This session discusses precision medicine, implementation strategies, and learning health systems to deliver more targeted, evidence-based treatments. The content is grounded in high-impact, peer reviewed literature to ensure scientific rigor.

Key learning objectives include:

• Design considerations for imaging in trials.
• Considerations for precision imaging in trials.
• Emerging applications of precision imaging in trials.

Take advantage of our live Q&A session at the conclusion of the webinar.

One CME credit is available.  CE Language

*Registered attendees will receive access to the on-demand video recording by Monday, August 11, 2025. You will receive an email notification with instructions on accessing the video. You may register for the on-demand webinar any time after the live webinar.

When:

USA - August 5, 2025 at 8:00pm ET | 5:00pm PT
UK- August 6, 2025 at 1:00am BST
Australia- August 6, 2025 at 10:00am AEST

Cost:
Member: $25
Trainee Member: FREE
Non-Member: $50

> >Register Now <<

About the Speakers

Aristotle Voineskos, MD, PhD, FRCPC
Dr. Aristotle Voineskos is the Senior Vice President, Research and Science & Director of the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH). At both CAMH and the University Health Network (UHN), he serves as the joint Vice President for the CAMH-UHN Partnership. Dr. Voineskos earned his MD and PhD at the University of Toronto, and completed a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. Dr. Voineskos is a Professor of Psychiatry at the
Temerty Faculty of Medicine. He is an internationally recognized researcher, physician, and leader, who has been dedicated to helping people suffering from severe mental illness and brain disorders.

Dr. Voineskos has served in progressive clinical and research leadership roles across his career. In these roles, he has significantly improved access to care, reduced wait times, and implemented and scaled evidence-based care models across the health system. Most recently as Vice President Research at CAMH, he helped grow the research enterprise substantially, via key pillars of equity, training and evaluation, clinical-research integration, open science, digital transformation, and sustainability. He is known for driving innovation and enhancing team performance. As joint Vice President of the CAMH-UHN Partnership, he helps lead the work across executive teams to deliver comprehensive physical and mental health care for patients, and accelerate advancements in brain health sciences.

Dr. Voineskos has published over 300 papers many of which are in the leading journals of psychiatry, neurology, medicine, and neuroscience. He has won numerous awards for his research and mentorship including the A.E. Bennett Award for Clinical/Translational Research from the Society of Biological Psychiatry (SOBP) in 2022 and the Joel Elkes Research Award from the American College of Neuropsychopharmacology (ACNP) in 2024